Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:52:07 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



News for U:INO from 2025-02-07 to 2026-02-06 - 31 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-12-29 08:05U:INONews ReleaseFDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
2025-12-19 16:05U:INONews ReleaseINOVIO Reports Inducement Grant Under Inducement Plan
2025-11-18 08:05U:INONews ReleaseINOVIO to Participate in December Investor Conferences
2025-11-11 08:40U:INONews ReleaseINOVIO Announces Pricing of $25 Million Public Offering
2025-11-10 18:09U:INONews ReleaseINOVIO Announces Proposed Public Offering
2025-11-10 16:05U:INONews ReleaseINOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
2025-11-03 08:05U:INONews ReleaseINOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
2025-10-31 16:53U:INONews ReleaseINOVIO Reports Inducement Grant Under Inducement Plan
2025-10-27 08:05U:INONews ReleaseINOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
2025-10-23 16:05U:INONews ReleaseINOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
2025-10-21 08:05U:INONews ReleaseClinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
2025-10-02 08:05U:INONews ReleaseINOVIO Reports Inducement Grant Under Inducement Plan
2025-09-25 08:05U:INONews ReleaseINOVIO to Participate in Upcoming Scientific Conferences
2025-08-26 08:05U:INONews ReleaseINOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
2025-08-25 08:05U:INONews ReleaseINOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-12 16:05U:INONews ReleaseINOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
2025-08-11 08:05U:INONews ReleaseData Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)
2025-08-04 16:05U:INONews ReleaseINOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
2025-07-07 16:05U:INONews ReleaseINOVIO to Present at Upcoming Scientific Conference
2025-07-03 07:30U:INONews ReleaseINOVIO Announces Pricing of $25 Million Public Offering
2025-07-02 16:16U:INONews ReleaseINOVIO Announces Proposed Public Offering
2025-07-01 07:00U:INONews ReleaseAvacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
2025-05-13 16:05U:INONews ReleaseINOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights
2025-04-30 08:05U:INONews ReleaseINOVIO to Present at Upcoming Scientific and Investor Conferences
2025-04-29 08:05U:INONews ReleaseINOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
2025-04-09 08:05U:INONews ReleaseINOVIO to Present at Upcoming Scientific Conferences
2025-03-18 16:05U:INONews ReleaseINOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
2025-03-13 18:15U:INONews ReleaseINOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
2025-03-12 12:55U:INONews ReleaseINOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
2025-02-12 08:00U:INONews ReleaseClinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
2025-02-10 08:05U:INONews ReleaseImmune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference